Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
Cells · 30.03.2024 · 13 (7) · 606
DOI: 10.3390/cells13070606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 30.03.2024. Verfasst von Giulia Magni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pain Therapy and Neuroimmunology, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, via Balzar…. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Neuroglia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR).
Abstract (Originalsprache)
In vitro and preclinical in vivo research in the last 35 years has clearly highlighted the crucial physiopathological role of glial cells, namely astrocytes/microglia/oligodendrocytes and satellite glial cells/Schwann cells in the central and peripheral nervous system, respectively. Several possible pharmacological targets to various neurodegenerative disorders and painful conditions have therefore been successfully identified, including receptors and enzymes, and mediators of neuroinflammation. However, the translation of these promising data to a clinical setting is often hampered by both technical and biological difficulties, making it necessary to perform experiments on human cells and models of the various diseases. In this review we will, therefore, summarize the most relevant data on the contribution of glial cells to human pathologies and on their possible pharmacological modulation based on data obtained in post-mortem tissues and in iPSC-derived human brain cells and organoids. The possibility of an in vivo visualization of glia reaction to neuroinflammation in patients will be also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Pain Therapy and Neuroimmunology, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, via Balzaretti, 9, 20133 Milan, Italy.
ORCID-Profile: Giulia Magni, Benedetta Riboldi, Stefania Ceruti
Förderung
- Italian Ministry of University and Research (MUR)
Zitieren
APA
Magni, G., Riboldi, B., & Ceruti, S. (2024). Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies. Cells, 13(7), 606. https://doi.org/10.3390/cells13070606
Vancouver
Magni G, Riboldi B, Ceruti S. Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies. Cells. 2024;13(7):606. doi:10.3390/cells13070606
BibTeX
@article{Magni2024,
author = {Magni, Giulia and Riboldi, Benedetta and Ceruti, Stefania},
title = {Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies},
journal = {Cells},
year = {2024},
volume = {13},
number = {7},
pages = {606},
doi = {10.3390/cells13070606}
}
EUVIMED